Product Information
CYCLOBENZAPRINE 10 MG TABLET is a generic product labeled by KVK-Tech Inc., priced at $0.0181 per EA under NDC 10702000709. Its NADAC has been published 306 times since Jan 15, 2020.
FDA first approved this application on Feb 28, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
KVK-Tech Inc.NDC
10702000709
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
11/19/2025
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078048FDA Approved
2/28/2011
TE Code
AB
On Market Since
7/31/2014
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 10 MG TABLET has been published 306 times since Jan 15, 2020, and over the history we have for it it has declined 28.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0181 per EA |
|---|---|
| All-time high | $0.0275 (Dec 16, 2020) |
| All-time low | $0.0144 (Nov 20, 2024) |
| 52-week high | $0.0192 |
| 52-week low | $0.0181 |
| Median price | $0.0225 |
| Average price | $0.0222 |
| Largest weekly change | +32.5% (Jun 19, 2024) |
| Weeks tracked | 306 |
| Tracking since | Jan 15, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-5.5%
3Y
-17.7%
5Y
-26.2%
All
-28.3%
Last surveyed Nov 19, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 10 MG TABLET, manufactured by KVK-Tech Inc., is $0.0181 per EA (NDC 10702000709), effective Nov 19, 2025.
How has the price of CYCLOBENZAPRINE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 10 MG TABLET has declined 28.3%. It has been tracked across 306 weekly CMS publications since Jan 15, 2020.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 10 MG TABLET?
Since Jan 15, 2020, the NADAC for CYCLOBENZAPRINE 10 MG TABLET has ranged from a low of $0.0144 (Nov 20, 2024) to a high of $0.0275 (Dec 16, 2020), with a median of $0.0225 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 10 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CYCLOBENZAPRINE 10 MG TABLET, is $0.0169 per EA — about 6% below CYCLOBENZAPRINE 10 MG TABLET.
Who manufactures CYCLOBENZAPRINE 10 MG TABLET?
CYCLOBENZAPRINE 10 MG TABLET (NDC 10702000709) is labeled by KVK-Tech Inc., and CMS classifies it as a generic product.